Markets:

Overview

News

Currencies

International

Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

12.04 +0.23 (+1.95%)

Streaming Delayed Price Updated: 12:49 PM EDT, May 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

32 33 Next >

Small Pharma, Biomind Labs Among Top Psychedelic Movers Of Today ↗

August 29, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 27.51% at $0.18

Via Benzinga

Largest Psychedelic Compound-Based Drug Stocks On A Roll - Up 50% Since End Of June ↗

August 26, 2022

The Psychedelic Compounds-Based Drug Stocks Index went up 9.8% this week and is now up 49.5% since the end of June albeit down 32.6% YTD.

Via Talk Markets

Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗

August 26, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 3.61% at $1.00 LOSERS:

Via Benzinga

Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗

August 24, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 17.87% at $1.22

Via Benzinga

Psychedelic Stock Gainers And Losers From August 23, 2022 ↗

August 23, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 5.33% at $14.24

Via Benzinga

Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

August 22, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 10.34% at $0.16

Via Benzinga

Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today ↗

August 19, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 29.35% at $0.14 LOSERS:

Via Benzinga

Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

August 18, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From August 17, 2022 ↗

August 17, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From August 16, 2022 ↗

August 16, 2022

Via Benzinga

These Depression Players Are Top Picks For $400B Mental Healthcare Market, Says Analyst ↗

August 16, 2022

HC Wainwright expects COMPASS Pathways Plc (NASDAQ: CMPS) and Cybin Inc (NYSE: CYBN) to be leaders in the emerging $400 billion mental healthcare market.

Via Benzinga

Allied, Cybin Among Top Psychedelic Movers Of Today ↗

August 15, 2022

Via Benzinga

Major Psychedelic Stocks Down This Week; Still Up Since End Of June ↗

August 14, 2022

The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then.

Via Talk Markets

Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today ↗

August 12, 2022

Via Benzinga

Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

August 11, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From August 10, 2022 ↗

August 10, 2022

Via Benzinga

3 Best Psychedelic Stocks to Buy Now ↗

August 09, 2022

These are three of the best psychedelic stocks to buy to get in on the next generation of treatment for mental health disorders.

Via InvestorPlace

Cybin, Field Trip Health Among Top Psychedelic Movers Of Today ↗

August 09, 2022

Via Benzinga

Compass Pathways to Begin New Phase 2 Psychedelic Trial for Anorexia

August 09, 2022

Via Investor Brand Network

BREAKING: COMPASS Pathways Sued For Alleged Theft Of Psilocybin Trade Secrets ↗

August 09, 2022

Terran Biosciences Inc. is suing COMPASS Pathways (NASDAQ: CMPS) for the appropriation of trade secrets.

Via Benzinga

GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

August 05, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80

Via Benzinga

Psychedelic Stock Gainers And Losers From August 4, 2022 ↗

August 04, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17

Via Benzinga

Compass Pathways Reports Q2 Financial Results, R&D Expenses Keep Growing ↗

August 04, 2022

COMPASS Pathways plc (NASDAQ: CMPS) released financial results for the second quarter 2022 and gave an update on recent progress across its business. Q2 2022 Financial Highlights

Via Benzinga

ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today ↗

August 02, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82

Via Benzinga

ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗

August 01, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34

Via Benzinga

July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD ↗

July 30, 2022

Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more.

Via Talk Markets

Psychedelic Stock Gainers And Losers From July 29, 2022 ↗

July 29, 2022

GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22

Via Benzinga

Allied, Cybin Among Top Psychedelic Movers Of Today ↗

July 28, 2022

GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55

Via Benzinga

Psilocybin For Anorexia: Learn About Compass' Novel Phase 2 Trial Using Magic Mushroom's Main Compound ↗

July 28, 2022

Psychedelics mental healthcare company Compass Pathways PLC. (NASDAQ: CMPS) has launched a phase 2 clinical study testing the efficacy of psilocybin with psychological support in people with anorexia...

Via Benzinga

Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗

July 27, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.